Teladoc Health Inc. (TDOC)
6.83
-0.07 (-1.01%)
At close: Apr 17, 2025, 3:59 PM
6.83
0.00%
After-hours: Apr 17, 2025, 07:57 PM EDT
Teladoc Health Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|
| Other.. Revenue | 85.23M | 82.8M | 88.96M | 86.61M | 78.17M | 76.75M | 78.37M | 284.27M |
| Other.. Revenue Growth | +2.94% | -6.93% | +2.71% | +10.80% | +1.85% | -2.08% | -72.43% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 |
|---|---|
| Non-Us Revenue | 364.88M |
| Non-Us Revenue Growth | n/a |
| United States Revenue | 2.24B |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 339.17M | 330.26M | 349.39M | 148.09M | 301.87M | 358.13M | 345.43M | 322.57M | 346.1M | 333.37M | 296.85M | 290.92M | 276.7M | 278.29M | 259.4M | 531.68M | 135.53M | 122.88M | 96.8M | 88.11M | 87.76M | 83.02M | 79.69M | 75.55M | 68.54M | 60.37M | 58.59M | 57.96M | 47.76M | 35.75M | 35.44M | 31.39M | 30.04M | 26.9M | 26.93M | 24.8M | 22.65M | 25.61M | 19.99M |
| Selling, General, and Administrative Revenue Growth | +2.70% | -5.48% | +135.93% | -50.94% | -15.71% | +3.68% | +7.09% | -6.80% | +3.82% | +12.30% | +2.04% | +5.14% | -0.57% | +7.28% | -51.21% | +292.30% | +10.29% | +26.95% | +9.86% | +0.41% | +5.71% | +4.17% | +5.49% | +10.23% | +13.54% | +3.03% | +1.08% | +21.35% | +33.60% | +0.89% | +12.88% | +4.51% | +11.67% | -0.10% | +8.57% | +9.51% | -11.58% | +28.13% | n/a |
| Research and Development Revenue | 72.38M | 76.75M | 81.39M | 89.94M | 84.29M | 87.31M | 86.98M | 82.93M | 87.81M | 80.83M | 87.41M | 72.87M | 80.25M | 80.76M | 78.01M | 92.7M | 29.96M | 23.03M | 19.26M | 16.25M | 15.75M | 16.66M | 15.99M | 13.54M | 13.58M | 14.35M | 12.9M | 10.45M | 9.96M | 7.54M | 6.51M | 5.89M | 5.87M | 4.83M | 5.22M | 4.16M | 3.94M | 3.2M | 2.91M |
| Research and Development Revenue Growth | -5.69% | -5.70% | -9.51% | +6.70% | -3.46% | +0.37% | +4.89% | -5.56% | +8.65% | -7.53% | +19.96% | -9.20% | -0.63% | +3.53% | -15.85% | +209.42% | +30.09% | +19.59% | +18.53% | +3.18% | -5.51% | +4.24% | +18.04% | -0.24% | -5.37% | +11.19% | +23.53% | +4.84% | +32.20% | +15.74% | +10.49% | +0.46% | +21.50% | -7.58% | +25.60% | +5.56% | +23.04% | +10.22% | n/a |
| Sales and Marketing Revenue | 224.93M | 220.71M | 237.69M | 53.01M | 186.15M | 218.41M | 231.28M | 202.72M | 233.55M | 222.5M | 191.93M | 172.32M | 173.68M | 167.08M | 154.23M | 187.69M | 75.78M | 66.27M | 50.45M | 42.11M | 47.44M | 42.45M | 42.62M | 38.06M | 37.97M | 34.12M | 34.11M | 29.72M | 25.72M | 19.6M | 20.6M | 17.27M | 16.71M | 13.66M | 13.32M | 10.67M | 10.39M | 9.13M | 8.02M |
| Sales and Marketing Revenue Growth | +1.91% | -7.15% | +348.41% | -71.52% | -14.77% | -5.56% | +14.09% | -13.20% | +4.97% | +15.93% | +11.38% | -0.78% | +3.95% | +8.33% | -17.83% | +147.67% | +14.37% | +31.33% | +19.83% | -11.24% | +11.76% | -0.39% | +11.96% | +0.24% | +11.29% | +0.04% | +14.76% | +15.55% | +31.22% | -4.86% | +19.30% | +3.37% | +22.28% | +2.58% | +24.88% | +2.61% | +13.89% | +13.76% | n/a |